Grants
The Experimental Therapeutics Institute funds pilot projects grants. The purpose of these grants is to encourage collaborative projects between researchers in different disciplines to develop interdisciplinary projects and gather initial data that would make applications to extramural agencies more competitive. The proposals focus on development of new high risk/high gain ideas. The grants aim to foster collaborative research that is translational in nature with a focus on development of new therapeutics. Purely basic or clinical studies do not in general fall within the scope of this pilot project program. Although these projects generally have multiple PIs, single PI applications that are collaborative are considered. These projects generally represent a new translational direction for the PI(s).
2010-2011 Funded Pilot Projects
Application of CBPR to Increase Exclusive Breastfeeding in Diverse Communities [Abstract]
Development of a Novel Dendritic Cell Vaccine for Patients with Castration-Resistant Metastatic Prostate Cancer [Abstract]
Exome Sequencing for Cardiovascular Traits [Abstract]
Improving Liver Repopulation of Embryonic Stem Cell-derived Hepatic Cells [Abstract]
Obstructive Sleep Apnea Syndrome and Pre-Diabetes in East Harlem: a Pilot Study to Assess the Feasibility of Portable Sleep Apnea Monitoring and Prevalence of Sleep Apnea in Individuals with Pre-Diabetes [Abstract]
The Use of Recombinant Human Acid Ceramidase for ex vivo Hematopoietic Stem Cell Expansion [Abstract]
2009-2010 Funded Pilot Projects
Assessing Cognitive Decline during Breast Cancer [Abstract]
CEACAM5 as a Marker of Differentiation between Crohn's Disease and Ulcerative Colitis [Abstract]
Economic Analysis of Current Treatment Options for Clinically Localized Prostate Cancer [Abstract]
Evaluation of Genetic and Immune Markers to Predict HCV Recurrence after Liver Transplantation [Abstract]
Human Derived 3-D Engineered Cardiac Tissue for Clinically Translatable in vitro Screening Applications [Abstract]
Identification and Treatment of Epigenetic Changes in Hepatocellular Carcinoma [Abstract]
Impact of H1N1 Influenza Virus Vaccine upon Memory B Cell Populations in Adults of Different Ages [Abstract]
Kinetics of Innate Immune Responses Control HIV/AIDS Disease [Abstract]
Microarray-based Approach to Develop Non-Invasive Biomarkers in Eosinophilic Esophagitis [Abstract]
Role of Insulin Signaling in Regulating Thalamic MDN Gene Expression [Abstract]
The Multipotency of Epicardial Cells and Mammalian Cardiac Repair and Regeneration [Abstract]
Therapeutic Assessment of Combined Endovascular Aneurysm Repair (EVAR) Stent Grafting and Stem Cell Therapy in Porcine Models of Abdominal Aortic Aneurysms [Abstract]
Understanding Barriers Toward Research Participation: Perceptions of Study Risk, Burden, and Limited Public Trust [Abstract]
2008-2009 Funded Pilot Projects
A Novel Screen for Therapeutics to Treat Fatty Liver Disease [Abstract]
Host Dendritic Cell Vaccination for Prevention or for Treatment of Relapsed Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematological Malignancies [Abstract]
Isolation and Characterization of Human Induced Pluripotent Stem Cell Cardiomyocytes from Patients with Idiopathic Cardiomyopathy [Abstract]
Nicotinamide Riboside as a Novel Therapeutic for Atherosclerosis: Evaluation using Magnetic Resonance Imaging of Macrophage Migration [Abstract]
Towards Novel Therapeutics for Alzheimer’s Disease using a Structure Guided High-Throughput Screening Approach [Abstract]
Experimental Therapeutics Institute
Tel: 212-659-1710
Send e-mail

